Lipoxin A4 (LXA4) versus Nanolipoxin A4 (Nano-LXA4) for osteosarcoma.

Saved in:
Bibliographic Details
Title: Lipoxin A4 (LXA4) versus Nanolipoxin A4 (Nano-LXA4) for osteosarcoma.
Authors: Gomes-da-Silva NC; Brazilian Nuclear Energy Commission, Nuclear Engineering Institute, Laboratory of Nanoradiopharmacy and Synthesis of New Radiopharmaceuticals, Rio de Janeiro, RJ 21941906, Brazil., Cavalcanti A; Unidade de Pesquisa Experimental em Ortopedia, Instituto Nacional de Traumatologia e Ortopedia (INTO), Rio de Janeiro 20940070, Brazil., Alves G; Unidade de Pesquisa Experimental em Ortopedia, Instituto Nacional de Traumatologia e Ortopedia (INTO), Rio de Janeiro 20940070, Brazil., Meohas W; Centro de Atenção Especializada em Oncologia Ortopédica Instituto Nacional de Traumatologia e Ortopedia (INTO), Rio de Janeiro 20940070, Brazil., Facchetti B; Centro de Atenção Especializada em Oncologia Ortopédica Instituto Nacional de Traumatologia e Ortopedia (INTO), Rio de Janeiro 20940070, Brazil., Perini JA; Research Laboratory of Pharmaceutical Sciences (LAPESF), Pharmacy Department (DepFarm), Rio de Janeiro State University (UERJ), Rio de Janeiro 23070-200, Brazil., Rebelo Alencar LM; Federal University of Maranhão, Department of Physics, Biophysics Laboratory, Campus Bacanga, São Luís, MA 65080-805, Brazil., Ricci-Junior E; LADEG, Laboratory of Pharmaceutical Nanotechnology, Faculty of Pharmacy, DEFARMED, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil., Fechine PBA; Group of Chemistry of Advanced Materials (GQMat), Department of Analytical Chemistry and Physical-Chemistry, Federal University of Ceará, Fortaleza, CE 451-970, Brazil., Barja-Fidalgo TC; Laboratory of Cellular & Molecular Pharmacology, Department of Cell Biology, Instituto de Biologia Roberto Alcantara Gomes (IBRAG), Universidade do Estado do Rio de Janeiro, Rio de Janeiro 20551030, RJ, Brazil., Rosas EC; Laboratory of Applied Pharmacology, Farmanguinhos, Oswaldo Cruz Foundation, Rio de Janeiro 21040-360, Brazil., Santos-Oliveira R; Brazilian Nuclear Energy Commission, Nuclear Engineering Institute, Laboratory of Nanoradiopharmacy and Synthesis of New Radiopharmaceuticals, Rio de Janeiro, RJ 21941906, Brazil; State University of Rio de Janeiro, Laboratory of Nanoradiopharmacy and Strategic Biomaterials, Rio de Janeiro, RJ 220000, Brazil. Electronic address: roliveira@ien.gov.br.
Source: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V [Eur J Pharm Biopharm] 2026 Sep; Vol. 226, pp. 115132. Date of Electronic Publication: 2026 Jun 03.
Publication Type: Journal Article; Comparative Study
Journal Info: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 9109778 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-3441 (Electronic) Linking ISSN: 09396411 NLM ISO Abbreviation: Eur J Pharm Biopharm Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first